Letter to the Editor: Hepatic steatosis and glycemic burden in chronic hepatitis B

Shang-Chin Huang^{1

2

3

4}, Jia-Horng Kao^{2

3

4}

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
³ Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
⁴ Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

Comment

Shang-Chin Huang et al. Hepatology. 2023.

. 2023 Jul 1;78(1):E11.

doi: 10.1097/HEP.0000000000000371. Epub 2023 Mar 20.

Shang-Chin Huang^{1

2

3

4}, Jia-Horng Kao^{2

3

4}

¹ Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
³ Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
⁴ Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

No abstract available

Comment in

Reply: Hepatic steatosis and glycemic burden in chronic hepatitis B.
Mak LY, Yuen MF, Seto WK. Mak LY, et al. Hepatology. 2023 Jul 1;78(1):E12-E13. doi: 10.1097/HEP.0000000000000374. Epub 2023 Mar 22. Hepatology. 2023. PMID: 36929950 No abstract available.

Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes.
Mak LY, Hui RW, Lee CH, Mao X, Cheung KS, Wong DK, Lui DT, Fung J, Yuen MF, Seto WK. Mak LY, et al. Hepatology. 2023 Feb 1;77(2):606-618. doi: 10.1002/hep.32716. Epub 2022 Sep 21. Hepatology. 2023. PMID: 36130882

1. Mak LY, Hui RW, Lee CH, Mao X, Cheung KS, Wong DK, et al. Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes. Hepatology. 2023;77:606–618.
1. Mak LY, Hui RW, Fung J, Liu F, Wong DK, Li B, et al. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection. Hepatol Int. 2021;15:901–911.